This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.



Cannabis research has increased in recent years as more territories have legalized the use of marijuana for medical and recreational purposes. The increase in legal access has led to a corresponding increase in scientific interest, with researchers eager to study cannabis's potential uses and effects. the latest and most promising cannabis research trends.

Modern cultivation and production techniques:
As the cannabis industry’s revenue increases, more companies invest in modern cultivation techniques and controlled agricultural practices. This includes developing and using advanced growing systems such as hydroponics and aeroponics and applying genetic engineering to create new strains with specific desired characteristics.

Increasing focus on the therapeutic potential of cannabidiol:
Cannabidiol (CBD) is a non-psychoactive compound found in the cannabis plant. Unlike tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, CBD does not produce a "high" and has gained significant attention in cannabis research.
Considering the potential beneficial effects of CBD on human health, more research needs to be conducted to ensure its safety and efficacy. This includes the development of quality assurance standards for testing, which is currently a research gap. In addition, the development of high CBD, low THC cannabis strains through molecular breeding holds promise to accelerate cannabis research progress.

Minor cannabinoids taking center stage:
Minor cannabinoids have not been studied as extensively as CBD or THC. Still, recent research has shown potential therapeutic benefits for conditions such as neuropathic pain, neurodegenerative diseases, epilepsy, cancer, and skin disorders.
As researchers deepen their understanding of the cannabis plant and its compounds, we will likely better understand the health benefits of minor cannabinoids and how they could be applicable in the pharmaceutical industry.

New and improved delivery systems for cannabis-based medicines:

A significant challenge in developing cannabis-based medicines is finding effective ways to deliver active compounds to the body. Traditional methods of ingestion, such as smoking, can harm people’s health and may not provide consistent dosing. Moreover, low aqueous solubility and poor bioavailability hinder the effective clinical development of oral cannabinoid formulations.
The use of nanotechnology to deliver cannabis-based medicines is another promising research topic.
Transdermal patches, which allow for the slow release of active compounds through the skin, are also gaining popularity as cannabinoid delivery systems.
The development of improved methods to deliver cannabis-based medicines is an active area of research and holds enormous potential for future treatments.

Cannabis research expands due to changes in the legal landscape:

Researchers, clinicians, and regulatory officials must collaborate to ensure that phyto cannabinoid products meet necessary therapeutic and safety standards. This can be achieved by:
- Conducting well-designed clinical trials
- Establishing guidelines for the production, labeling, and testing of cannabis
- Creating systems to monitor and report adverse events
- Collaborating on the development of education and information resources.
By taking these steps, regulators and practitioners ensure that patients can access safe and  effective phytocannabinoid products while protecting the public’s health.

Subscribe to our News & Updates